Albireo AB

ACTIVE

Arvid Wallgrens Backe 20, Göteborg, Västra Götaland, Swedenwww.albireopharma.comPublic101–250 employeesEstablished: 2008-01-01

Clinical Trials

47 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2008

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

87.0%

Phase 3

9.3%

Trial Status Distribution

Active, not recruiting

85.2%

Completed

3.7%

Not yet recruiting

1.9%

Recruiting

9.3%

Clinical Trials

Trials sponsored by this organization (54)

This Study Will Investigate the Efficacy and Safety of Odevixibat in Children with Biliary Atresia Who Have Undergone a Kasai HPE

Phase 1

Active, not recruiting

interventional

Jun 2024228 participants

A long term Investigation of the Safety and Efficacy of Odevixibat in Patients with Alagille syndrome

Phase 1

Recruiting

interventional

Dec 202350 participants

An Open Label Study to Evaluate A3907 in Adults with Primary Sclerosing Cholangitis (PSC)

Phase 1

Recruiting

interventional

Aug 202225 participants

An extension study to evaluate the long-term efficacy and safety of odevixibat (A4250) in children with biliary atresia (BOLD-EXT)

Phase 1

Recruiting

interventional

Jun 2022184 participants

A long term Investigation of the Safety and Efficacy of Odevixibat in Patients with Alagille syndrome

Phase 1

Active, not recruiting

Jan 202260 participants

A long term Investigation of the Safety and Efficacy of Odevixibat in Patients with Alagille syndrome

Phase 1

Active, not recruiting

Nov 202160 participants

A long term Investigation of the Safety and Efficacy of Odevixibat in Patients with Alagille syndrome

Phase 1

Active, not recruiting

Sep 202151 participants

A long term Investigation of the Safety and Efficacy of Odevixibat in Patients with Alagille syndrome

Phase 1

Active, not recruiting

Sep 202150 participants

Page 1 of 7

Approvals

No approval data available

News

No news articles found

Back to Organizations